BLUEJET

Blue Jet Healthcare Financial Results

₹542.30+0.77%
Market cap
₹9,407 crore
P/E
40.1
P/B
6.92
ROE
19.9%
Dividend yield
0.22%

For the year ended Mar 2023, Blue Jet Healthcare reported revenue of ₹721 crore and net profit of ₹160 crore, against ₹710 crore and ₹164 crore a year earlier.

Blue Jet Healthcare annual profit and loss

Financial years, newest first. TTM = trailing twelve months.

Blue Jet Healthcare annual profit and loss (₹ crore)
ItemMar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue7217101,026944883
Expenses501480648650612
Operating profit219231378294271
Operating margin %30%32%37%31%31%
Other income2418466976
Interest10066
Depreciation2528182425
Profit before tax217220406333316
Tax %26%26%25%25%26%
Net profit160164305248235
EPS (₹)9.239.4417.5914.2913.54
Dividend payout %—————

Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.

Blue Jet Healthcare financial results — frequently asked questions

What is Blue Jet Healthcare's annual revenue and net profit?

For the financial year ended Mar 2023, Blue Jet Healthcare's revenue was ₹721 crore and net profit ₹160 crore; net profit fell 2.44% from ₹164 crore in Mar 2024.

How fast has Blue Jet Healthcare grown over three years?

From Mar 2026 to Mar 2023, Blue Jet Healthcare's revenue grew at a compound annual rate of -8.6% and net profit at -13.6%. Past growth does not indicate future results.

What is the EPS of Blue Jet Healthcare?

Annual EPS for Mar 2023 was ₹9.23.

Are these figures consolidated or standalone?

They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.

Same Data For Peers

Trade Blue Jet Healthcare With ATS

Track BLUEJET live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.